DRD2 and prolactin-producing pituitary gland adenoma: The primary objective of this study was to determine if resistant prolactinomas express D2R protein as assessed by immunohistochemistry, with the aim of avoiding unnecessary use of high-dose dopamine agonists in D2R negative prolactinomas.